Leaderboards/cancer mechanisms and therapy

cancer mechanisms and therapy

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Xianjing Chu
Central South University
99
2
Rongrong Zhou
Central South University
90
3
Wanchen Zhao
Jinan University
80
4
Andrew R Moorman
Memorial Sloan Kettering Cancer Center
60
5
Gustavo S. França
Institute for Systems Biology
40

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Kim Newton
Gene Therapy Laboratory
99
2
Md Entaz Bahar
Gyeongsang National University
90
3
Muhammad Javed Iqbal
University of Sialkot
80
4
Sameer Ullah Khan
The University of Texas MD Anderson Cancer Center
70
5
Guilan Quan
Jinan University
70
6
Xin Lin
Central South University
60
7
John D. Gordan
University of California, San Francisco
50
8
Karuna Ganesh
Memorial Sloan Kettering Cancer Center
50
9
Mohammad Chehelgerdi
Shahrekord University
40
10
Toshitaka Nakamura
Target (Germany)
30

Emerging Leaders Papers

1
Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation
Molecular Cancer|2023
956 cit.
2
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Signal Transduction and Targeted Therapy|2023
744 cit.
3
Unveiling the mechanisms and challenges of cancer drug resistance
Cell Communication and Signaling|2024
327 cit.
4
Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation
Nature Structural & Molecular Biology|2023
73 cit.
5
Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms
eLife|2023
32 cit.
6
Caspase cleavage of RIPK3 after Asp333 is dispensable for mouse embryogenesis
Cell Death and Differentiation|2024
15 cit.
7
cFLIP suppresses caspase-1- and MLKL-independent perinatal lethality driven by auto-processing impaired caspase-8 D387A
Cell Death and Differentiation|2025
2 cit.
8
Development of antibody-drug conjugates targeting L1CAM to treat metastatic cancer
bioRxiv (Cold Spring Harbor Laboratory)|2025
0 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
99
2
Jeremy N. Rich
Texas Neurology
90
3
Howard Y. Chang
Howard Hughes Medical Institute
80
4
Xin Yu
Amgen (United States)
70
5
Albert S. Baldwin
University of North Carolina at Chapel Hill
60
6
Luis A. Díaz
Swim Across America
50
7
Mostafa A. El‐Sayed
Georgia Institute of Technology
40
8
Raffaella Sordella
Cold Spring Harbor Laboratory
30
9
Itai Yanai
New York University
30
10
Deok Ryong Kim
Gyeongsang National University
20

All-Time Leaders Papers

1
Pembrolizumab versus Ipilimumab in Advanced Melanoma
New England Journal of Medicine|2015
5.8k cit.
2
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
New England Journal of Medicine|2016
3.1k cit.
3
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
New England Journal of Medicine|2020
2.9k cit.
4
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Nature|2010
2.5k cit.
5
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
New England Journal of Medicine|2014
2k cit.
6
Immunotherapy in colorectal cancer: rationale, challenges and potential
Nature Reviews Gastroenterology & Hepatology|2019
2k cit.
7
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Cell Reports|2017
1.9k cit.
8
Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification
Bioinformatics|2004
1.4k cit.
9
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
JAMA|2016
1.1k cit.
10
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
The Lancet Oncology|2022
872 cit.

Reagents for cancer mechanisms and therapy

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Thermo Fisher Scientific

Cyclin D1 Monoclonal Antibody (DCS-6), Biotin

Cited in 13 papers
#MA562366
View Evidence →Thermo Fisher Scientific

Cyclin D1 Recombinant Rabbit Monoclonal Antibody (5D8)

Cited in 13 papers
#MA5-60676
View Evidence →Cell Signaling Technology

Phospho-MCM2 (Ser139) Antibody

Cited in 13 papers
#8861$362
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

CDK8 (D6M3J) Rabbit Monoclonal Antibody

Cited in 19 papers
#17395$161
View Evidence →Thermo Fisher Scientific

Cyclin D1 Recombinant Rabbit Monoclonal Antibody (RM241)

Cited in 13 papers
#MA562110
View Evidence →Thermo Fisher Scientific

Cyclin D1 Recombinant Rabbit Monoclonal Antibody (HL2219)

Cited in 13 papers
#MA5-56668
View Evidence →